TANGANIL

Hypoallergenic -Suitable for

Sensitive skin.

This medicine is indicated for the symptomatic treatment of the dizzying crisis in adults.

Hypersensitivity reactions (may be severe, e. g. anaphylactoid shock, laryngeal oedema) have been observed and treatment should be discontinued from the first signs of hypersensitivity after administration of acetylleucine.

Pharmacotherapeutic group

ANTIVERTIGINOUS, ATC code: N07CA04.

Adverse reactions are classified as follows by class of organ systems MedDRA and frequency.

Frequency is defined according to the following convention: very common (≥ 1/10), common (≥ 1/100 and < 1/10), uncommon (≥ 1/1,000 and < 1/100), rare (≥ 1/10,000 and < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data).

D-ORGANES (MedDRA Classification) Very rare Not known Immune system disorders Hypersensitivity reactions, anaphylactoid shock and laryngeal oedema Skin and subcutaneous tissue disorders Skin reactions (sometimes associated with pruritus), erythema, urticaria General disorders and administration site conditions Reactions to the site d-dsuppression (such as pain, oedema or haematoma) Reporting of suspected adverse reactions following authorization of the drug is important.

It allows for continued monitoring of the network of medicinal products and adverse health conditions.

For external use only.

Keep out ofreach of children.Avoid contact with eyes.

Approximately 0.2-0.4 oz each time.